gip glp 1 agonist GLP-1 & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) Free Comparison Chart: GLP-1 and

Emerging research on the potential benefits of GLP-1swhich include semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro and Zepbound)for treating PCOS suggests Nirchi may be far from alone in finding this type of drug life-changing

The improved regulation of glycemia by GLP-1RA, along with their ability to reduce lipid synthesis, enhanced beta oxidation of free fatty acids and autophagy of fat cells contributes to their lipid modulation properties (59)

They enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite via central hypothalamic pathways, leading to lower energy intake and improved glycemic control

doi: 10.1164/rccm.202007-2906ED

Ministerio de Sanidad, Spain)

2 The APA article notes that many patients discontinue treatment within a year because of side effects, cost, access issues, or other challenges, but this source does not establish mental distress as a uniform or primary reason across all patients